Navigation Links
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Anthera Pharmaceuticals, Inc. (ANTH)
Date:1/17/2017

NEW YORK, Jan. 17, 2016 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Anthera Pharmaceuticals, Inc. ("Anthera" or the "Company") (NASDAQ: ANTH). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/anth.  

The investigation concerns whether Anthera and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.

On November 10, 2016, Anthera released that "the CHABLIS-SC1 clinical trial with blisibimod for the treatment of systemic lupus erythematosus (SLE) failed to meet its primary endpoint based upon the SLE Responder Index-6 (SRI-6) at 52 weeks." Then on December 27, 2016, Anthera made public that its SOLUTION Phase 3 Study for liprotamase also failed to meet its primary endpoint and Anthera said it would conduct a new liprotamase study. During this time, Anthera stock dropped 73%, from a previous close on November 9, 2016 of $2.78 per share to a close of $0.74 per share on December 28, 2016. 

If you are aware of any facts relating to this investigation, or purchased Anthera shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/anth. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484. 

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:  
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-anthera-pharmaceuticals-inc-anth-300391195.html


'/>"/>
SOURCE Bronstein, Gewirtz & Grossman, LLC
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. TNI BioTech, Inc. Corporations CEO Issues Letter to Shareholders Discussing Recent Events
2. Medifirst Solutions, Inc. Announces Update To Shareholders
3. SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intuitive Surgical, Inc. - ISRG
4. 3SBio Inc. Announces Shareholders Approval of the Amended Merger Agreement
5. SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on Their Investment in AMAG Pharmaceuticals, Inc. of Class Action Lawsuit Investigation - AMAG
6. Royalty Pharma Recommends Elan Shareholders vote "NO" on each of the Elan Resolutions at the Elan extraordinary general meeting
7. Cytos Invites to the Annual Shareholders Meeting 2013
8. CVBT Shareholders Vote for Change
9. Royalty Pharma Urges Elan Shareholders to Vote AGAINST ALL FOUR Elan Resolutions Today
10. Millenia Hope, Inc. Updates to Shareholders
11. Sinovac Schedules 2013 Annual Meeting of Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2019)... ... September 17, 2019 , ... Scientists writing in a 2017 ... stop the progressive destruction of joint cartilage in osteoarthritis are “on the close ... upper limb orthopedic surgeon Alejandro Badia, MD , founder and chief medical ...
(Date:9/17/2019)... (PRWEB) , ... September 17, 2019 , ... ... Periodontics located in Moorestown and Medford, NJ, now welcome patients from Cherry Hill, ... strives to save natural teeth whenever possible. When tooth removal is necessary, they ...
(Date:9/17/2019)... ... ... the 6th year in a row, Mental Health America (MHA) released its annual ... of Columbia based on several mental health and access measures. This year, Pennsylvania came out ... on the trends of the last 6 years and shows that many are still not ...
Breaking Medicine Technology:
(Date:9/17/2019)... ... September 17, 2019 , ... ... Warriors , with the goal of providing resources to assist researchers and encourage ... a progressive disease causing abnormal iron deposits in the brain. , BPAN ...
(Date:9/17/2019)... ... September 17, 2019 , ... ... day on Pacifica's Lambert Campus, 249 Lambert Road, Carpinteria, CA. The day ... Clinical Psychology, Counseling Psychology, and Mythological Studies. Program Faculty will host program-specific ...
(Date:9/12/2019)... ... September 12, 2019 , ... Donaldson ... national scale in two recent and well-renowned listing publications, the Inc. 5000 and ... for the 2019 year. , Dr. Jeffrey Donaldson, CEO and owner of ...
(Date:9/11/2019)... ... ... A September 2 article on CBS News details a new ... to suffer heart attacks, strokes, kidney failure, and heart disease versus a control group ... specialists Dr. Feiz and Associates says the study adds further evidence to an overwhelming ...
(Date:9/11/2019)... N.J. (PRWEB) , ... September 11, 2019 , ... ... management, will exhibit at the 2019 AHIMA Health Data and Information Conference in ... to stop by booth #505 to learn more about GRM’s healthcare information ...
Breaking Medicine News(10 mins):